December 18, 2020 | Nora Samaranayake

Robert Gallo, MD, The Homer & Martha Gudelsky Distinguished Professor in Medicine, co-founder and director of the Institute Human Virology at the University of Maryland School of Medicine and co-founder and international scientific advisor of the Global Virus Network, was awarded Italy’s “Magna Graecia International Prize,” an award created in 1997 by the Magna Graecia Foundation that is bestowed to the most influential Italians and Italians of origin who have embodied and symbolized, in the most diverse sectors, the best qualities of Italy by extending Italian culture beyond national borders.
“I am honored to award the Prize to a Magna Graecia son, to a man who inherits in his genes the highest values of Western culture,” said Hon. Nino Foti, President of the Magna Graecia Foundation.
“Dr. Robert Gallo's contribution to the whole of humanity derives precisely from his roots in Magna Graecia, the ancient incubator of Western civilization and medical science were figures of gigantic proportion such as Alcmeone and Pythagoras laid the foundations of the Krotonian school of medicine and the Italic Pythagorean School, respectively. It was these two geniuses who with their revolutions covered the birth of science and sprouted the bud of the human personality, an indication of a new approach to investigation and research, a rational anxiety aimed at the love of knowledge and the renaissance of nature.
"The innate feeling of the state of health animated the desire to understand the morbid phenomena and the causes that generated them. ‘Knowing oneself,’ as Socrates liked to repeat, through the modern exploration of origins is certainly a goal worth fighting for. Dr. Robert Gallo is the living testimony inherited from this origin in the past, the legacy of those ancient experiences, a monumental knowledge that today helps us to understand the profound meaning of one’s own attitude towards life, death and destiny”.
Previous awardees include the President of the Argentine Republic Mauricio Macri, the Governor of the State of New York George Pataki, the Minister of Foreign Trade of Canada Sergio Marchi, the Argentine Minister of Tourism Francisco Mayorga, the Chairman and CEO of Grupo Globo - the largest mass media group in Brasil and Latin America - Roberto Irineu Marinho, the President of Mediaset - the largest mass media company and commercial broadcaster in Italy – Fedele Confalonieri, the Dean of Central University of Venezuela Giannetto Pace, former U.S. Congressman and NIAF National Italian American Foundation Chairman Hon. Frank Guarini, the Dean of Rio de Janeiro State University Nilcea Freire, the Italian State Accountant Andrea Monorchio, the President of Columbus Citizen Foundation Louis Tallarini, the director-screenwriter and film producer Oscar prize Giuseppe Tornatore, the songwriter and record producer Tony Renis, the Commissioner Fire Department of New York Daniel Nigro and the playwright and seven Tony Awards winner Mario Fratti. Last year, the Prize was awarded to the physicist Federico Faggin, inventor of the microchip and father of the touchscreen. A special career recognition has been given to Fulvio Lucisano, film producer and founder of the IIF Italian International Film.
“The award bestowed upon Dr. Gallo by the Foundation is given in recognition of his prolific and magnificent contributions to the science of virology,” said Arthur J. Gajarsa, senior counsel at WilmerHale and member of the Institute of Human Virology at the University of Maryland School of Medicine Board of Advisors. “But he is also a humanist whose scientific research in the field has saved thousands of lives in all parts of the world. This award also recognizes his family roots in Italy of which Dr. Gallo is very proud.”
“It is with heartfelt appreciation that I accept this honor because not only is it a privilege, the recognition has personal meaning since a significant part of my family comes from the region of Calabria and Puglia,” said Dr. Robert Gallo. “I truly love this part of Italy, in particular, Sicily and its island. I also enjoy ancient Greek mythologies and ancient cultures of southern Italy.”
Since 1996, Dr. Gallo has been Co-Founder and Director of the Institute of Human Virology and Professor of Medicine at the University of Maryland School of Medicine. He is also the Gudelsky Distinguished Professor in Medicine and Co-Founder and International Science Advisor of the Global Virus Network (GVN).
Previously (for 30 years) he was at the National Cancer Institute (NCI) in Bethesda, MD. While at NCI, he and his co-workers discovered interleukin-2 (Il-2) in 1976. Il-2 was the first cytokine (“messenger” molecule that allows cells to communicate and alter one another’s function) and proved to be a major tool for immunology and the discovery of all human retroviruses.
Dr. Gallo and his colleagues then opened and pioneered human retrovirology with the discovery of the first human retrovirus (HTLV-1) and, along with Japanese investigators, showed it was a cause of a particular form of human leukemia.
A year later, he and his group discovered the second known human retrovirus (HTLV-2). Dr. Gallo and his colleagues also co-independently discovered HIV, provided the first results showing that HIV was the cause of AIDS, and developed the life-saving HIV blood test. In 1986, he and his colleagues discovered human herpes virus-6 (HHV-6), the first new herpes virus found in more than 25 years, and in 1995 discovered the first endogenous inhibitors of HIV, namely some of the beta chemokines. This helped find the HIV co-receptor, CCR5, and opened up entirely new approaches to the treatment of HIV disease.
Dr. Gallo has been awarded 35 honorary doctorates from 12 countries, is a member of the U.S. National Academy of Sciences and Institute of Medicine (National Academy of Medicine) and is a member of the National Inventors Hall of Fame. He is also the recipient of numerous worldwide scientific honors and awards. According to the Institute for Scientific Information, Dr. Gallo was the most cited scientist in the world 1980-1990, and he was ranked third in the world for scientific impact for the period 1983-2002. He has published close to 1,300 papers.
About the Institute of Human Virology
Formed in 1996 as a partnership between the State of Maryland, the City of Baltimore, the University System of Maryland, and the University of Maryland Medical System, the IHV is an institute of the University of Maryland School of Medicine and is home to some of the most globally-recognized and world-renowned experts in all of virology. The IHV combines the disciplines of basic research, epidemiology, and clinical research in a concerted effort to speed the discovery of diagnostics and therapeutics for a wide variety of chronic and deadly viral and immune disorders - most notably, HIV the virus that causes AIDS. For more information, visit www.ihv.org and follow us on Twitter @IHVmaryland.
About the University of Maryland School of Medicine
Now in its third century, the University of Maryland School of Medicine was chartered in 1807 as the first public medical school in the United States. It continues today as one of the fastest growing, top-tier biomedical research enterprises in the world -- with 45 academic departments, centers, institutes, and programs; and a faculty of more than 3,000 physicians, scientists, and allied health professionals, including members of the National Academy of Medicine and the National Academy of Sciences, and a distinguished two-time winner of the Albert E. Lasker Award in Medical Research. With an operating budget of more than $1.2 billion, the School of Medicine works closely in partnership with the University of Maryland Medical Center and Medical System to provide research-intensive, academic and clinically based care for nearly 2 million patients each year. The School of Medicine has more than $563 million in extramural funding, with most of its academic departments highly ranked among all medical schools in the nation in research funding. As one of the seven professional schools that make up the University of Maryland, Baltimore campus, the School of Medicine has a total population of nearly 9,000 faculty and staff, including 2,500 student trainees, residents, and fellows. The combined School of Medicine and Medical System (“University of Maryland Medicine”) has an annual budget of nearly $6 billion and an economic impact more than $15 billion on the state and local community. The School of Medicine, which ranks as the 8th highest among public medical schools in research productivity, is an innovator in translational medicine, with 600 active patents and 24 start-up companies. The School of Medicine works locally, nationally, and globally, with research and treatment facilities in 36 countries around the world. Visit medschool.umaryland.edu
Contact
Institute of Human Virology
Nora Samaranayake
Director of Marketing and Public Relations
(410) 706-8614 (phone)
(410) 706-1952 (fax)
nsamaranayake@ihv.umaryland.edu
Related stories

Monday, April 19, 2021
Bloomberg TV: Will Vaccines Protect Us From All Covid-19 Variants?
Dr. Robert Gallo, co-founder of the Global Virus Network and director of the Institute of Human Virology at the University of Maryland School of Medicine, discusses the global rollout of Covid-19 vaccines. Global cases passed 141 million, and deaths exceeded 3 million. Gallo speaks with Haidi Stroud-Watts and Shery Ahn on "Bloomberg Daybreak: Australia."

Monday, April 19, 2021
China Business Network: An interview with Dr. Gallo on COVID-19, Variants and Vaccines
In an exclusive interview with CBN, Dr. Robert Gallo, a world-renowned virus expert, speculated that certain components of Johnson & Johnson and AstraZeneca vaccines may induce the immune system to produce an antibody, which can cause a very small number of people. Heparin-induced thrombocytopenia, thrombosis.

Friday, April 09, 2021
Aljazeera: Which vaccine is best? The one you can get first, experts say
As the United States ramps up its COVID-19 inoculation campaign, aiming to make vaccines available to all adults by April 19, some doctors and health workers are concerned that brand preferences among potential vaccine recipients could hurt attempts to slow the spread of the virus.

Thursday, April 01, 2021
Associated Press: Can I still spread the coronavirus after I’m vaccinated?
Can I still spread the coronavirus after I’m vaccinated? It’s possible. Experts say the risk is low, but are still studying how well the shots blunt the spread of the virus. The current vaccines are highly effective at preventing people from getting seriously sick with COVID-19.

Monday, December 21, 2020
Robert Gallo of the UM School of Medicine Institute of Human Virology and Global Virus Network Awarded Top Life Sciences and Medicine Prize from China
Robert C. Gallo, MD, The Homer & Martha Gudelsky Distinguished Professor in Medicine, co-founder and director of the Institute Human Virology at the University of Maryland School of Medicine and co-founder and international scientific advisor of the Global Virus Network, was awarded the “VCANBIO Award for Biosciences and Medicine,” a significant and authoritative award in the life sciences and medicine field of China. The elite Prize is jointly presented by the University of Chinese Academy of Sciences and the VCANBIO CELL & GENE ENGINEERING CORP, LTD to push forward scientific research, technological innovation and continuous development in the life sciences and medicine field of China.

Thursday, October 08, 2020
NPR: Could The Live Flu Vaccine Help You Fight Off COVID-19?
In case you were still procrastinating getting a flu shot this year, here's another reason to make it a priority. There's a chance the vaccine could offer some protection against COVID-19 itself, says virologist Robert Gallo, who directs the Institute of Human Virology at the University of Maryland School of Medicine and is chairman of the Global Virus Network.

Thursday, September 24, 2020
Baltimore Sun: A vaccine will help, not end coronavirus pandemic, experts in Maryland and globally say
A global group of virus experts warned Thursday about relying too much on the first vaccines to end the coronavirus pandemic. “If we get a perfect vaccine, great, but that’s unlikely,” said Dr. Robert Gallo, co-founder of the Global Virus Network, during a news conference following a meeting of the organization that works to understand and treat infectious diseases.

Friday, August 21, 2020
Institute of Human Virology and Italian Researchers identify a SARS-CoV-2 Viral Strain with Deletion in a Protein, Possibly Reducing Fatalities
The Institute of Human Virology (IHV) at the University of Maryland School of Medicine, a Global Virus Network (GVN) Center of Excellence, in collaboration with scientists from Campus Biomedico in Rome, Italy announced today the results of studies showing the emergence of a SARS-CoV-2 viral strain with a deletion in a protein known as nsp1. These data, accepted for publication today by the Journal of Translational Medicine, (link here) may indicate the emergence of a less pathogenic viral strain.

Tuesday, June 30, 2020
Wall Street Journal Op-Ed: An Old Vaccine May Help Against Coronavirus: A tablet for polio boosts innate immunity, which fights other viruses.
In this op-ed coauthored by Dr. Robert C. Gallo and Daniel J. Arbess, they discuss how “An Old Vaccine May Help Against Coronavirus: A tablet for polio boosts innate immunity, which fights other viruses.”

Monday, June 29, 2020
Baltimore Magazine Special Edition: Dr. Gallo Featured
Dr. Robert Gallo is featured in Baltimore Magazine's special edition, "On the Front Lines: Acts of Courage and Kindness in the Age of Coronavirus."

Thursday, June 11, 2020
Global Virus Network Suggests Oral Polio Vaccine May Provide Temporary Protection Against COVID-19
The Global Virus Network (GVN), a coalition comprised of the world’s preeminent human and animal virologists from 53 Centers of Excellence, including the Institute of Human Virology at the University of Maryland School of Medicine, and 10 Affiliates in 32 countries, published a viewpoint in Science today that the stimulation of innate immunity by live attenuated vaccines in general, and oral poliovirus vaccine (OPV) in particular, could provide temporary protection against coronavirus disease 2019 (COVID-19).

Friday, May 01, 2020
NYT Op-Ed Features Gallo-Chumakov Oral Polio Vaccine for COVID-19 Idea
What if We Already Have a Coronavirus Vaccine? Researchers are testing whether decades-old vaccines for polio and tuberculosis could protect against infection.

Wednesday, April 29, 2020
Dr. Robert Gallo Appears on C-SPAN’s Washington Journal
Please check out Dr. Robert Gallo’s C-SPAN Washington Journal appearance today to discuss COVID-19 treatments, vaccines, the need for the Global Virus Network, and more.

Monday, April 27, 2020
Expert Breaks Down Coronavirus Research: Is it Worse than HIV? Is it Mutating?
IHV Co-Founder and Director, Robert Gallo, MD is interviewed on LBC, a radio station in the United Kingdom. Darren Adam had Professor Gallo on the line to discuss his research in the past and the work he's carrying out during the coronavirus crisis. "We have learned to live with HIV" Darren began, listing out how it has changed from a death sentence to a disease that humans can live a long life with. He wondered if this could be possibly the path we're taking with Covid-19.

Wednesday, April 22, 2020
Dr. Robert Gallo on India Today Discussing the Oral Polio Vaccine for COVID-19
IndiaToday on Twitter - “Can oral polio vaccine help in fighting #Covid19? @DrRobertCGallo responds. #NewsToday with @sardesairajdeep

Friday, April 17, 2020
Dr. Robert Gallo Discusses Repurposing the Oral Polio Vaccine on CNN
Dr. Robert Gallo discusses repurposing the oral polio vaccine, drug therapies and more on COVID-19 on CNN’s The Lead with Jake Tapper, April 17, 2020.

Monday, April 13, 2020
Can an Oral Polio Vaccine Stop COVID-19?
Please see this just released Associated Press article, “Could old vaccines for other germs protect against COVID-19?” with Dr. Robert Gallo (Institute of Human Virology at the University of Maryland School of Medicine) and Dr. Konstantin Chumakov (U.S. Food and Drug Administration), both of the Global Virus Network (GVN).

Wednesday, April 08, 2020
Institute of Human Virology Co-founder on Coronavirus Recovery, Antibody Testing, Drug Testing, Bloomberg TV
Dr. Robert Gallo, the Institute of Human Virology at the University of Maryland School of Medicine, Co-founder and director discusses the coronavirus. He speaks with Haidi Stroud-Watts and Shery Ahn on "Bloomberg Daybreak: Asia." (Source: Bloomberg)

Tuesday, April 07, 2020
A Deep Look Into The Coronavirus with Dr. Robert Gallo on WYPR (Baltimore’s local NPR station)
(WNPR) Dr. Robert Gallo has been getting to know viruses-- their targets and their weaknesses--for decades, even before he co-discovered the virus that causes AIDS in the 1980s. At the University of Maryland’s Institute for Human Virology, which he heads, Gallo is looking at the coronavirus; he joins us to share his thoughts. Gallo is also co-founder and international scientific advisor at the Global Virus Network.

Wednesday, April 01, 2020
Dr. Robert Gallo Featured on MSNBC’s 11th Hour with Brian Williams
Robert Gallo, MD, Co-Founder and Director of the Institute of Human Virology, discusses SARS-CoV-2/COVID-19, specifically, how he thinks the fight against the Coronavirus is going thus far.

Friday, October 04, 2019
Institute of Human Virology Hosts 21st Annual International Meeting of Top Scientists on Ending the HIV/AIDS Epidemic in America and the Intersection of Opioid Use Disorder
The Institute of Human Virology (IHV) at the University of Maryland School of Medicine commenced IHV2019 held Thursday, October 3 through Friday, October 4 at the Four Seasons Hotel in Baltimore, Maryland. This year “Progress in HIV/AIDS: Challenges in 2020” opened with highlights about the recent plan for "Ending the HIV Epidemic by 2030” with expert opinions by ADM Brett Giroir, MD, Assistant Secretary for Health at the U.S. Department of Health and Human Services (HHS)

Monday, August 26, 2019
Dr. Robert Gallo Featured in Malcolm Gladwell's Podcast, "Revisionist History: The Obscure Virus Club"
"Revisionist History" by Malcolm Gladwell: “The Obscure Virus Club,” featuring three prominent virologists, including Dr. Robert Gallo (as well as Dr. Ludwig Gross and Dr. Howard Temin).